Evidence map›Paper›PMID 30317676›Full record

ArticlePediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology2019

Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid.

Nikolaos Douladiris, Victoria Garib, Margit Focke-Tejkl, Rudolf Valenta, Nikolaos G Papadopoulos, Birgit Linhart

Open access · hybridAbstract read
In one paragraph

Article in Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. A novel recognition of the major allergen, Hum j 1, fromThe World Allergy Organization journal · 2025
    Article
  3. Article
  4. Review
  5. Recombinant allergens for immunotherapy: state of the art.Current opinion in allergy and clinical immunology · 2019
    Review
  6. Detection of genuine grass pollen sensitization in children by skin testing with a recombinant grass pollen hybrid.Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 4 countries.

Nikolaos DouladirisAllergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.
Victoria GaribDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Margit Focke-TejklDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Rudolf ValentaDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.
Nikolaos G PapadopoulosAllergy Department, 2nd Pediatric Clinic, University of Athens, Athens, Greece.ORCID 0000-0002-4448-3468
Birgit LinhartDivision of Immunopathology, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology and Immunology, Medical University of Vienna, Vienna, Austria.ORCID 0000-0001-6857-3049
Medical University of Vienna · ATNational and Kapodistrian University of Athens · GRSechenov University · RU

Funding

Austrian Science Fund F4605Austrian Science Fund P29991Austrian Science Fund FWF F 4605Austrian Science Fund FWF P 29991
6 · The paper itself

Abstract

backgroundSkin testing represents a commonly used first diagnostic method in clinical practice, but allergen extracts may vary in composition and often contain cross-reactive allergens and therefore do not always allow the precise identification of the sensitizing allergen source. Our aim was to investigate the suitability of a single recombinant hybrid molecule, consisting of the four major timothy grass pollen allergens (Phl p 1, Phl p 2, Phl p 5, and Phl p 6) for in vivo diagnosis of genuine grass pollen allergy in children suffering from pollinosis.

methodsSixty-four children aged from 6 to 17 years with a positive skin reaction and/or specific IgE to grass pollen extract and respiratory symptoms of pollinosis as well as 9 control children with allergy to other allergen sources were studied. SPT was performed with the recombinant hybrid, the four recombinant timothy grass pollen allergens, and grass pollen extract. Specific IgE reactivity to 176 micro-arrayed allergen molecules was determined using ImmunoCAP ISAC technology. IgE reactivity to the hybrid was detected by non-denaturing RAST-based dot blot assay.

resultsGenuine grass pollen sensitization was confirmed in 94% of the children with positive SPT to grass pollen extract by SPT and IgE reactivity to the hybrid. The four hybrid-negative children showed IgE reactivity to cross-reactive allergens such as Phl p 4, Phl p 11, and Phl p 12 and had also sensitizations to pollen allergens from unrelated plants.

conclusionsThe recombinant hybrid molecule represents a useful tool for in vivo diagnosis of genuine grass pollen sensitization.

Indexed as

AdolescentAllergensChildHumansImmunoblottingImmunoglobulin EPlant ProteinsPollenRecombinant Fusion ProteinsRhinitis, Allergic, SeasonalSkin TestsAllergensImmunoglobulin EPlant ProteinsRecombinant Fusion Proteinsallergenallergymolecular diagnosispollenrecombinant hybrid allergenrespiratory allergyskin prick test

Identifiers

PMID30317676
PMCPMC6378406
OpenAlexW2897464145

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.